Experiences and perceptions of patients, caregivers, and healthcare professionals with long-acting injectable antipsychotics for the treatment of schizophrenia

Qualitative results from the multinational Advance study

Bibliographic Data

ID15523175
AuthorsKelli R Franzenburg (Teva Pharmaceuticals (Czechia), corresponding author), Rolf Hansen (Teva Pharmaceuticals (United States)), Mark Suett (0000-0002-6840-1535, TES Global (United Kingdom)), Ayelet Yaari (0000-0003-4782-8203, Teva Pharmaceuticals (Israel)), Martin Sergerie (Global Affairs Canada), Anna S Levin (0000-0003-2427-8368, Teva Pharmaceuticals (Israel)), Aviva Peyser Levin, Sigal Kaplan (0000-0002-5371-7748, Teva Pharmaceuticals (Israel)), Alma Patricia González (0000-0002-3401-7519, Teva Pharmaceuticals (Czechia)), Alma Gonzalez, Kameron Sedigh (Syneos Health (United States)), Stephan Here (0000-0002-1351-003X, Isar-Amper-Klinikum München-Ost), Stephan Heres, Martha Sajatovic (0000-0002-3073-668X, University Hospitals of Cleveland)
Year2025
Volume16
Pages1645328-1645328
Publication date2025-12-09
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2025.1645328
PMID41446293
OpenAlexW4417146301
LanguageEN
Citations received1
References cited30

Interactions between patients with schizophrenia and psychiatrists or psychiatric nurses vary depending on the care setting, which can influence the acceptance of LAIs. Initial schizophrenia presentation, family support, hospitalizations, trust in HCPs, and logistical challenges may all play a role in patient outcomes and perceptions of LAIs

Health care · Health professionals · Multinational corporation · Perception · Qualitative research · Schizophrenia (object-oriented programming · Family Caregiving in Mental Illness · Mental Health and Patient Involvement · Schizophrenia research and treatment

Tools

Open DOIOpen Access